Dap Gayrimenkul Gelistirme AS
IST:DAPGM.E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dap Gayrimenkul Gelistirme AS
IST:DAPGM.E
|
TR |
|
E
|
Eli Lilly and Co
SWB:LLY
|
US |
Income Statement
Earnings Waterfall
Dap Gayrimenkul Gelistirme AS
Income Statement
Dap Gayrimenkul Gelistirme AS
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
19
|
18
|
36
|
120
|
178
|
293
|
393
|
339
|
343
|
366
|
372
|
442
|
493
|
0
|
0
|
0
|
|
| Revenue |
929
N/A
|
1 047
+13%
|
1 692
+62%
|
7 814
+362%
|
3 954
-49%
|
5 111
+29%
|
6 167
+21%
|
10 297
+67%
|
8 066
-22%
|
9 565
+19%
|
9 624
+1%
|
8 882
-8%
|
8 138
-8%
|
7 259
-11%
|
6 966
-4%
|
8 010
+15%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(468)
|
(515)
|
(697)
|
(3 572)
|
(1 702)
|
(2 249)
|
(2 601)
|
(3 553)
|
(2 673)
|
(2 260)
|
(2 100)
|
(1 914)
|
(1 401)
|
(1 630)
|
(1 443)
|
(2 018)
|
|
| Gross Profit |
461
N/A
|
532
+16%
|
995
+87%
|
4 243
+326%
|
2 253
-47%
|
2 862
+27%
|
3 566
+25%
|
6 743
+89%
|
5 484
-19%
|
7 017
+28%
|
7 237
+3%
|
6 968
-4%
|
6 358
-9%
|
5 629
-11%
|
5 523
-2%
|
5 992
+8%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(138)
|
(144)
|
(186)
|
(497)
|
(306)
|
(344)
|
(366)
|
(562)
|
(413)
|
(389)
|
(334)
|
(340)
|
(235)
|
(316)
|
(344)
|
(473)
|
|
| Selling, General & Administrative |
(142)
|
(148)
|
(190)
|
(495)
|
(313)
|
(338)
|
(362)
|
(565)
|
(405)
|
(383)
|
(328)
|
(331)
|
(239)
|
(253)
|
(271)
|
(386)
|
|
| Depreciation & Amortization |
(1)
|
(2)
|
(2)
|
(9)
|
(4)
|
(9)
|
(10)
|
(21)
|
(26)
|
(26)
|
(31)
|
(31)
|
(25)
|
(37)
|
(41)
|
(40)
|
|
| Other Operating Expenses |
5
|
6
|
6
|
6
|
11
|
4
|
6
|
24
|
18
|
20
|
25
|
21
|
29
|
(26)
|
(32)
|
(47)
|
|
| Operating Income |
323
N/A
|
389
+20%
|
809
+108%
|
3 745
+363%
|
1 947
-48%
|
2 518
+29%
|
3 199
+27%
|
6 181
+93%
|
5 386
-13%
|
5 608
+4%
|
5 882
+5%
|
6 628
+13%
|
4 787
-28%
|
5 313
+11%
|
5 179
-3%
|
5 519
+7%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
(5)
|
(3)
|
2
|
(14)
|
(38)
|
(70)
|
(117)
|
(285)
|
82
|
(75)
|
37
|
(81)
|
182
|
239
|
84
|
(801)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
(1)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
1
|
|
| Total Other Income |
0
|
0
|
0
|
(1 295)
|
(12)
|
(22)
|
(33)
|
(3 281)
|
(3 563)
|
(3 790)
|
(4 885)
|
(4 689)
|
(3 737)
|
(4 060)
|
(3 784)
|
(3 054)
|
|
| Pre-Tax Income |
318
N/A
|
386
+21%
|
811
+110%
|
2 436
+200%
|
1 897
-22%
|
2 425
+28%
|
3 050
+26%
|
2 615
-14%
|
1 906
-27%
|
1 743
-9%
|
1 035
-41%
|
1 857
+80%
|
1 235
-34%
|
1 494
+21%
|
1 480
-1%
|
1 665
+12%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
(58)
|
(71)
|
(155)
|
(490)
|
(362)
|
(634)
|
(830)
|
(293)
|
(333)
|
(72)
|
(56)
|
(773)
|
(545)
|
(609)
|
(491)
|
(621)
|
|
| Income from Continuing Operations |
260
|
315
|
656
|
1 946
|
1 534
|
1 791
|
2 220
|
2 322
|
1 573
|
1 671
|
979
|
1 084
|
690
|
885
|
989
|
1 044
|
|
| Income to Minority Interest |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
260
N/A
|
314
+21%
|
656
+109%
|
1 946
+197%
|
1 535
-21%
|
1 791
+17%
|
2 220
+24%
|
2 322
+5%
|
1 573
-32%
|
1 671
+6%
|
979
-41%
|
1 084
+11%
|
690
-36%
|
885
+28%
|
989
+12%
|
1 044
+6%
|
|
| EPS (Diluted) |
1.3
N/A
|
1.57
+21%
|
1.7
+8%
|
0.79
-54%
|
3.98
+404%
|
4.65
+17%
|
5.77
+24%
|
0.94
-84%
|
0.63
-33%
|
0.65
+3%
|
0.36
-45%
|
0.72
+100%
|
0.26
-64%
|
0.33
+27%
|
0.37
+12%
|
0.39
+5%
|
|